Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e469f4f542d6d430759ed1bd1366b062 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-643 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-77 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 |
filingDate |
2013-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b95bc52349c2ea9b810777edce37124 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10ba74fcf64b9974f7e6a004d0ff02e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20f783c4a617dab659035437f8820ad7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9a567ed3afac7f4342c224cfcab4f63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b61aca93dc465dcc753eb0a12e19a131 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee53df7629a5d911284bed88a123bbbd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab22b44fd3676fff1ab875b185e533da |
publicationDate |
2017-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2013306018-B2 |
titleOfInvention |
Haptens of olanzapine |
abstract |
The invention relates to compounds of Formula I, wherein R |
priorityDate |
2012-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |